Vivos (RDGL) Gross Profit Growth (1y) (2011 - 2025)
Powered by 
Analysis
Vivos (RDGL) Gross Profit Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 15.59% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 21.17% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 13.68% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 17.10% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 12.38% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.54% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 20.68% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 20.50% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.95% |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 41.25% |
| Sep 30, 2025 | -1,285.48% |
| Jun 30, 2025 | -1,377.68% |
| Mar 31, 2025 | -505.53% |
| Dec 31, 2024 | 41.28% |
| Sep 30, 2024 | -84.56% |
| Jun 30, 2024 | 208.80% |
| Mar 31, 2024 | 2.34% |
| Dec 31, 2023 | -112.92% |
| Sep 30, 2023 | 207.12% |
| Jun 30, 2023 | -129.47% |
| Mar 31, 2023 | -115.36% |
| Dec 31, 2022 | 29.55% |
| Sep 30, 2022 | -173.53% |
| Dec 31, 2015 | -2.45% |
| Sep 30, 2015 | 4,648.30% |
| Jun 30, 2015 | -100.87% |
| Mar 31, 2015 | -15.50% |
| Dec 31, 2014 | -2,724.85% |
| Sep 30, 2014 | -101.71% |